Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 25)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
FDA Approves Invokana to Treat Type 2 Diabetes
March 29, 2013 – The U.S. Food and Drug Administration today approved Invokana (canagliflozin) tablets, used with diet and exercise, to improve glycemic control in adults with type 2 diabetes. Type...
FDA Medwatch Alert: Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication - Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas
ISSUE: FDA is evaluating unpublished new findings by a group of academic researchers that suggest an increased risk of pancreatitis and pre-cancerous cellular changes called pancreatic duct...
Takeda Receives FDA Approval for Kazano (alogliptin and metformin) for Type 2 Diabetes
DEERFIELD, Ill. and OSAKA, Japan, Jan. 25, 2013 /PRNewswire/ – Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced...
Takeda Receives FDA Approval for Oseni (alogliptin and pioglitazone) for Type 2 Diabetes
DEERFIELD, Ill. and OSAKA, Japan, Jan. 25, 2013 /PRNewswire/ – Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced...
Takeda Receives FDA Approval for Nesina (alogliptin) for Type 2 Diabetes
DEERFIELD, Ill. and OSAKA, Japan, Jan. 25, 2013 /PRNewswire/ – Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced...
Victoza Label Updated to Include Data Showing Superior Efficacy When Compared to Januvia
Princeton, N.J. (April 9, 2012) /PRNewswire/ - Novo Nordisk received approval from the U.S. Food and Drug Administration (FDA) to update the product label for Victoza (liraglutide [rDNA origin]...
FDA Approves Levemir Pregnancy Category Change for Women with Diabetes
Princeton, N.J. (April 02, 2012) /PRNewswire/ — Novo Nordisk, a world leader in diabetes care, announced today that the U.S. Food and Drug Administration (FDA) has approved Levemir (insulin detemir [...
FDA Approves Janumet XR (sitagliptin and metformin HCl extended-release) for Type 2 Diabetes, Offering the Powerful Efficacy of Janumet (sitagliptin/metformin HCl) Now Available with Once-Daily Convenience
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Feb 2, 2012 - Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved Janumet XR...
FDA Approves Jentadueto (linagliptin/metformin hydrochloride) for the Treatment of Adult Patients with Type 2 Diabetes
RIDGEFIELD, Conn., and INDIANAPOLIS, Jan. 30, 2012 /PRNewswire/ – Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has...
FDA Approves Bydureon - The First and Only Once-Weekly Treatment for Type 2 Diabetes
SAN DIEGO and DUBLIN, Jan. 27, 2012 /PRNewswire/ – Amylin Pharmaceuticals, Inc. and Alkermes plc today announced that the U.S. Food and Drug Administration (FDA) has approved Bydureon (exenatide...
FDA Approves Combination Therapy Juvisync
SILVER SPRING, Md., Oct. 7, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription...
Once-Daily Welchol (colesevelam HCl) for Oral Suspension Receives FDA Approval To be Mixed With Fruit Juice or Diet Soft Drinks
PARSIPPANY, N.J., July 25, 2011 /PRNewswire/ – Daiichi Sankyo, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol...
FDA Approves Updates to Lilly's Humalog (insulin lispro injection [rDNA origin]) Label
Update for Insulin Pump Use Provides an Additional Option for Children With Type 1 Diabetes and Extends Amount of Time People Can Use and Store Humalog Insulin in Their Pumps INDIANAPOLIS, June 8,...
FDA Approves Tradjenta for Type 2 Diabetes
SILVER SPRING, Md., May 2, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Tradjenta (linagliptin) tablets, used with diet and exercise, to improve blood glucose...
Kombiglyze XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 Diabetes Mellitus in Adults
PRINCETON, N.J. & LONDON--(BUSINESS WIRE)--Nov 5, 2010 - Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved Kombiglyze XR for the...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Mounjaro, Victoza, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... tirzepatide, Jardiance, liraglutide, Lantus Solostar, Humalog, Farxiga, Novolog, Janumet, insulin glargine, Januvia, Bydureon, insulin lispro, Tresiba, dulaglutide, Levemir, insulin degludec, Invokana, glimepiride, Glucophage, Humulin N